Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2005 Jul;42(7):547–550. doi: 10.1136/jmg.2004.026765

Is the Ala12 variant of the PPARG gene an "unthrifty allele"?

E Ruiz-Narvaez
PMCID: PMC1736098  PMID: 15994875

Abstract

Background: The thrifty genotype hypothesis proposes that genetic susceptibility to type 2 diabetes results from the positive selection of "thrifty" alleles in the past. A corollary of this hypothesis is that genetic variants protecting against the development of diabetes are "unthrifty" and thus subject to negative selection during human evolution.

Methods: It was assessed whether age estimates of the diabetes protective PPARG Ala12 allele indicate effects of natural selection. Based on published data from four populations, the date of origin of the diabetes protective PPARG Ala12 variant was estimated using both allele frequency and linkage disequilibrium (LD) with the C1431T single nucleotide polymorphism in exon 6 of the PPARG gene.

Results: The best LD based estimate of the age of the Ala12 allele gave an average of ∼32 000 years with a maximum upper bound of ∼58 000 years. Assuming a population with a growth rate of r = 0.01 per generation, the frequency based estimate of the age of the Ala12 variant gave an average of ∼27 000 years with a maximum upper bound of ∼42 000 years.

Discussion: The similarity of both time estimates is consistent with selective equivalence of the diabetes protective PPARG Ala12 allele and the diabetes susceptible PPARG Pro12 allele.

Full Text

The Full Text of this article is available as a PDF (90.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Shali Khalid Z., House Andrew A., Hanley Anthony J. G., Khan Hafiz M. R., Harris Stewart B., Zinman Bernard, Mamakeesick Mary, Fenster Aaron, Spence J. David, Hegele Robert A. Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke. 2004 Jul 29;35(9):2036–2040. doi: 10.1161/01.STR.0000138784.68159.a5. [DOI] [PubMed] [Google Scholar]
  2. Ardlie Kristin G., Lunetta Kathryn L., Seielstad Mark. Testing for population subdivision and association in four case-control studies. Am J Hum Genet. 2002 Jul 2;71(2):304–311. doi: 10.1086/341719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Auwerx J. PPARgamma, the ultimate thrifty gene. Diabetologia. 1999 Sep;42(9):1033–1049. doi: 10.1007/s001250051268. [DOI] [PubMed] [Google Scholar]
  4. Chakraborty R., Kamboh M. I., Nwankwo M., Ferrell R. E. Caucasian genes in American blacks: new data. Am J Hum Genet. 1992 Jan;50(1):145–155. [PMC free article] [PubMed] [Google Scholar]
  5. Deeb S. S., Fajas L., Nemoto M., Pihlajamäki J., Mykkänen L., Kuusisto J., Laakso M., Fujimoto W., Auwerx J. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998 Nov;20(3):284–287. doi: 10.1038/3099. [DOI] [PubMed] [Google Scholar]
  6. Doney Alex, Fischer Bettina, Frew David, Cumming Alastair, Flavell David M., World Michael, Montgomery Hugh E., Boyle Douglas, Morris Andrew, Palmer Colin N. A. Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet. 2002 Nov 13;3:21–21. doi: 10.1186/1471-2156-3-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Guo S. W., Xiong M. Estimating the age of mutant disease alleles based on linkage disequilibrium. Hum Hered. 1997 Nov-Dec;47(6):315–337. doi: 10.1159/000154431. [DOI] [PubMed] [Google Scholar]
  8. Hara K., Okada T., Tobe K., Yasuda K., Mori Y., Kadowaki H., Hagura R., Akanuma Y., Kimura S., Ito C. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun. 2000 Apr 29;271(1):212–216. doi: 10.1006/bbrc.2000.2605. [DOI] [PubMed] [Google Scholar]
  9. Hara Manami, Alcoser Sergio Y., Qaadir Arshia, Beiswenger Kristina K., Cox Nancy J., Ehrmann David A. Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. J Clin Endocrinol Metab. 2002 Feb;87(2):772–775. doi: 10.1210/jcem.87.2.8255. [DOI] [PubMed] [Google Scholar]
  10. Hegele R. A., Cao H., Harris S. B., Zinman B., Hanley A. J., Anderson C. M. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab. 2000 May;85(5):2014–2019. doi: 10.1210/jcem.85.5.6610. [DOI] [PubMed] [Google Scholar]
  11. Landi Stefano, Moreno Victor, Gioia-Patricola Lydie, Guino Elisabeth, Navarro Matilde, de Oca Javier, Capella Gabriel, Canzian Federico, Bellvitge Colorectal Cancer Study Group Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res. 2003 Jul 1;63(13):3560–3566. [PubMed] [Google Scholar]
  12. Mori Y., Kim-Motoyama H., Katakura T., Yasuda K., Kadowaki H., Beamer B. A., Shuldiner A. R., Akanuma Y., Yazaki Y., Kadowaki T. Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Commun. 1998 Oct 9;251(1):195–198. doi: 10.1006/bbrc.1998.9421. [DOI] [PubMed] [Google Scholar]
  13. NEEL J. V. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet. 1962 Dec;14:353–362. [PMC free article] [PubMed] [Google Scholar]
  14. Ridker Paul M., Cook Nancy R., Cheng Suzanne, Erlich Henry A., Lindpaintner Klaus, Plutzky Jorge, Zee Robert Y. L. Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction. Arterioscler Thromb Vasc Biol. 2003 Mar 27;23(5):859–863. doi: 10.1161/01.ATV.0000068680.19521.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sharma A. M. The thrifty-genotype hypothesis and its implications for the study of complex genetic disorders in man. J Mol Med (Berl) 1998 Jul;76(8):568–571. doi: 10.1007/s001090050251. [DOI] [PubMed] [Google Scholar]
  16. Slatkin M. Allele age and a test for selection on rare alleles. Philos Trans R Soc Lond B Biol Sci. 2000 Nov 29;355(1403):1663–1668. doi: 10.1098/rstb.2000.0729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Slatkin M., Rannala B. Estimating allele age. Annu Rev Genomics Hum Genet. 2000;1:225–249. doi: 10.1146/annurev.genom.1.1.225. [DOI] [PubMed] [Google Scholar]
  18. Stephens J. C., Reich D. E., Goldstein D. B., Shin H. D., Smith M. W., Carrington M., Winkler C., Huttley G. A., Allikmets R., Schriml L. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet. 1998 Jun;62(6):1507–1515. doi: 10.1086/301867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tai E. Shyong, Corella Dolores, Deurenberg-Yap Mabel, Adiconis Xian, Chew Suok Kai, Tan Chee Eng, Ordovas Jose M. Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res. 2004 Jan 16;45(4):674–685. doi: 10.1194/jlr.M300363-JLR200. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES